Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Anti-Cancer Drugs|April 1, 1992
Effect of luteinizing hormone-releasing hormone analogs containing cytotoxic radicals on growth of estrogen-independent MXT mouse mammary carcinoma in vivoK Szepeshazi, A V Schally, A Juhasz, et al.Preparative Biochemistry|January 1, 1988
Method for isolation of MMP-7-ase isoenzymes from rat muscle tissue extractJ G Guoth, I Sohar, M Zarandi, et al.Acta Neurologica Scandinavica|July 13, 2005
Kynurenine metabolism in multiple sclerosisZ Hartai, P Klivenyi, T Janaky, et al.International Journal of Peptide and Protein Research|December 1, 1988
New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analoguesS Bajusz, V J Csernus, T Janaky, et al.Biochemical Pharmacology|December 11, 1999
Molecular mechanism of the short-term cardiotoxicity caused by 2',3'-dideoxycytidine (ddC): modulation of reactive oxygen species levels and ADP-ribosylation reactionsG Skuta, G M Fischer, T Janaky, et al.International Journal of Peptide and Protein Research|January 1, 1993
Evaluation of biological activities of new LH-RH antagonists (T-series) in male and female ratsJ Pinski, T Yano, T Janaky, et al.International Journal of Peptide and Protein Research|March 1, 1992
Potent agonists of growth hormone-releasing hormone. Part IM Zarandi, P Serfozo, J Zsigo, et al.Peptide Research|July 1, 1992
Potent agonists of growth hormone-releasing hormone. IIM Zarandi, P Serfozo, J Zsigo, et al.Proceedings of the National Academy of Sciences of the United States of America|August 1, 1989
Highly potent metallopeptide analogues of luteinizing hormone-releasing hormoneS Bajusz, T Janaky, V J Csernus, et al.Proceedings of the National Academy of Sciences of the United States of America|March 1, 1988
Highly potent antagonists of luteinizing hormone-releasing hormone free of edematogenic effectsS Bajusz, M Kovacs, M Gazdag, et al.Pageof 2